Consenso uruguayo de manejo del infarto agudo de ... - SciELO
Consenso uruguayo de manejo del infarto agudo de ... - SciELO
Consenso uruguayo de manejo del infarto agudo de ... - SciELO
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
nitrates. Am Heart J 1985; 110: 216-24.<br />
26. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous<br />
nitrates on mortality in acute myocardial infarction: an overview of the<br />
randomised trials. Lancet 1988; 1: 1088-92.<br />
27. Gruppo Italiano per lo Studio <strong>de</strong>lla Sopravvivenza nell’<strong>infarto</strong><br />
Miocardico (GISSI). GISSI-3: effects of lisinopril and trans<strong>de</strong>rmal glyceryl<br />
trinitrate singly and together on 6- week mortality and ventricular function<br />
after acute myocardial infarction. Lancet 1994; 343: 1115-22.<br />
28. ISIS-4 (Fourth International Study of Infarct Survival)<br />
Collaborative Group. ISIS-4: a randomised factorial trial assessing early<br />
oral captopril, oral mononitrate, and intravenous magnesium sulphate in<br />
58,050 patients with suspected acute myocardial infarction. Lancet 1995;<br />
345: 669-85.<br />
29. Come PC, Pitt B. Nitroglycerin-induced severe hypotension and<br />
bradycardia in patients with acute myocardial infarction. Circulation 1976;<br />
54: 624-8.<br />
30. Kinch JW, Ryan TJ. Right ventricular infarction. N Engl J Med<br />
1994; 330: 1211-7.<br />
31. Cheitlin MD, Hutter AM, Brindis RG, Ganz P, Kaul S, Russell<br />
RO, et al. ACC/AHA expert consensus document, Use of sil<strong>de</strong>nafil<br />
(Viagra) in patients with cardiovascular disease: American College of<br />
Cardiology/American Heart Association. J Am Coll Cardiol 1999; 33: 273-<br />
82.<br />
32. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blocka<strong>de</strong> during<br />
and after myocardial infarction: an overview of the randomized trials. Prog<br />
Cardiovasc Dis 1985; 27: 335-71.<br />
33. First International Study of Infarct Survival Collaborative Group.<br />
Randomised trial of intravenous atenolol among 16 027 cases of suspected<br />
acute myocardial infarction: ISIS-1. Lancet 1986; 2:57-66.<br />
34. The MIAMI Trial Research Group. Metoprolol in acute myocardial<br />
infarction: patient population. Am J Cardiol 1985; 56: 10G-14G.<br />
35. Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ,<br />
Smith HC, et al. Immediate versus <strong>de</strong>ferred beta-blocka<strong>de</strong> following<br />
thrombolytic therapy in patients with acute myocardial infarction: Results of<br />
the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation<br />
1991; 83: 407-16.<br />
36. Van-<strong>de</strong>-Werf F, Janssens L, Brzostek T, et al. Short-term effects of<br />
early intravenous treatment with a beta-adrenergic blocking agent or a<br />
specific bradycardiac agent in patients with acute myocardial infarction<br />
receiving thrombolytic therapy. J Am Coll Cardiol 1993; 22: 407-16.<br />
37. Pfisterer M, Cox JL, Granger CB, Brener SJ, Naylor CD, Califf<br />
RM, et al. Atenolol use and clinical outcomes after thrombolysis for acute<br />
myocardial infarction: the GUSTO-I experience, Global Utilization of<br />
Streptokinase and TPA(alteplase) for Occlu<strong>de</strong>d Coronary Arteries. J Am